ClinicalTrials.gg
Enrolling by invitationNCT05014841Updated Sep 16, 2025

The Neural Coding of Speech Across Human Languages

An interventional study of Speech Tasks in Epilepsy, Brain Tumor and Speech, sponsored by University of California, San Francisco. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-09-16.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 5 years 10 months after the study started (first participant enrolled Sep 2015, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 15 studies in Epilepsy by University of California, San Francisco — 5 open to participants now, 7 under way, none of them phase 3. Epilepsy · University of California, San Francisco.

Started
2015
with 2 others
No phase
7 of 15
4 open now
Registered
9th of 15
by date

Among the 15 studies in Epilepsy by University of California, San Francisco, this one is one of 3 that started in 2015, is one of 7 with no phase, and was the 9th registered.

By phase

15 studies; the count open now beside each. This study's row is marked.

No phasethis study7 · 4 open
Observational7 · 1 open
Phase 11 · 0 open

By the year they started

First in 2003; this study’s year is marked. 3 started in 2015.

Size and results

Median enrollment 56 across the 8 interventional studies, 188 across the 7 observational. Of the 7 that completed or were terminated, 1 (14%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 15 studies in Epilepsy by University of California, San Francisco, or all of them as a file.
02

Study summary

The overall goal of this study is to reveal the fundamental neural mechanisms that underlie comprehension across human spoken languages. An understanding of how speech is coded in the brain has significant implications for the development of new diagnostic and rehabilitative strategies for language disorders (e.g. aphasia, dyslexia, autism, et alia). The basic mechanisms underlying comprehension of spoken language are unknown. Researchers are only beginning to understand how the human brain extracts the most fundamental linguistic elements (consonants and vowels) from a complex and highly variable acoustic signal. Traditional theories have posited a 'universal' phonetic inventory shared by all humans, but this has been challenged by other newer theories that each language has its own unique and specialized code. An investigation of the cortical representation of speech sounds across languages can likely shed light on this fundamental question. Previous research has implicated the superior temporal cortex in the processing of speech sounds. Most of this work has been entirely carried out in English. The recording of neural activity directly from the cortical surface from individuals with different language experience is a promising approach since it can provide both high spatial and temporal resolution. This study will examine the mechanisms of phonetic encoding, by utilizing neurophysiological recordings obtained during neurosurgical procedures. High-density electrode arrays, advanced signal processing, and direct electrocortical stimulation will be utilized to unravel both local and population encoding of speech sounds in the lateral temporal cortex. This study will also examine the neural encoding of speech in patients who are monolingual and bilingual in Mandarin, Spanish, and English, the most common spoken languages worldwide, and feature important contrastive differences of pitch, formant, and temporal envelope. A cross-linguistic approach is critical for a true understanding of language, while also striving to achieve a broader approach of diversity and inclusion in neuroscience of language.

Read the detailed description

Experimental approaches with significantly greater spatial and temporal resolution are necessary to directly resolve, both local- and population- level, the contrastive encoding of speech sounds. This study proposes an innovative methodological approach using customized intracranial high-density electrode arrays to record neural activity directly from nonprimary auditory cortex in patients undergoing clinical neurosurgical procedures (acute intraoperative and chronic extraoperative). This approach overcomes obstacles in traditional neuroimaging by offering high signal-to-noise recordings, unprecedented detailed spatiotemporal resolution, and a large number of simultaneously recorded cortical sites in awake, behaving subjects. The research study team will leverage the diversity of languages spoken by patients that are treated at the large volume epilepsy and tumor brain mapping programs at the University of California, San Francisco. They will examine cortical responses to speech stimuli (natural speech corpora and control tokens) in Spanish, Mandarin, and English speakers (monolingual and bilingual). They will also focus on encoding models in three fundamental domains of acoustic-phonetic cues that are present in all languages: pitch, formants, and amplitude envelope. The aims of this study seeks to determine how pitch cues encode lexical tone processing in Mandarin (Aim 1), the cortical representation of vowels in Spanish and English (Aim 2), and the encoding of the speech amplitude envelope in Spanish and English (Aim 3). Together, these aims will elucidate mechanistic principles of speech encoding in the human auditory cortex to understand what is shared and different across human spoken languages. Abnormalities in these fundamental processes have been implicated in a host of communication disorders such as dyslexia, developmental language disorder, central hearing loss, and aphasia. These results should heavily impact current theories of speech processing and, therefore, will have significant implications for understanding and remediating human disorders across different languages.

03

Conditions studied

  • Epilepsy
  • Brain Tumor
  • Speech
  • Bilingualism
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants with epilepsy or brain tumors at UCSF undergoing surgical electrode implantation for seizure localization or for speech and language mapping and
  • Participants with electrodes implanted in at least two regions of interest who are willing and able to cooperate with study tasks.

Exclusion criteria

Exclusion Criteria:

  • Participants who lack capacity or decline to provide ,
  • Participants who have significant cerebral lesions or
  • Participants with cognitive deficits that preclude reliable completion of study tasks.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Electrocorticography (ECoG) recording during Speech Tasks

    Participants listened to 20-minute Speech Tasks while ECoG signals for neural activity was recorded during their intraoperative procedure or inpatient hospitalization at the University of California, San Francisco (UCSF).

    Behavioral: Speech Tasks

Interventions

  • BehavioralSpeech Tasks

    Listen to 20-minutes of speech sounds in English, Spanish, and/or Mandarin.

06

What researchers measure

Primary outcomes

  1. Number of Participants with Electrocorticography (ECoG) Signals for Neural Activity Identified During Intraoperative Procedure or Inpatient Hospitalization

    Number of participants with ECoG signals for neural activity identified during intraoperative procedure or inpatient hospitalization, between 10-30 minutes.

    Time frame: Between 10-30 minutes

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — No Individual Participant Data (IPD) will be made available to other researchers; only de-identified data will be shared with Collaborators for research analysis.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05014841
Responsible party
Sponsor
First posted
Aug 20, 2021
Start date
Sep 14, 2015
Primary completion
Aug 31, 2026 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Sep 16, 2025

Study contacts

Edward F Chang, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion